Main market
Access this stock data via API
Subscribe
Towa Pharmaceutical Co., Ltd.
0
0
0%

Financials

Income statement

Fiscal date Jun 2025 Jun 2024 Mar 2024 Dec 2023
Total reported revenue 59.6B 60.9B
Cost of revenue 38.6B 38.8B
Gross profit 21.0B 22.2B
Operating expense
Research & development
Selling general and admin
Other operating expenses
Operating income 4.4B 6.2B
Non operating interest income
Income 49M 26M
Expense 273M 262M
Other income expense
Pretax income 7.2B 6.9B
Tax provision 2.5B 2.3B
Net income 4.7B 4.6B
Basic EPS 51.1 111.6
Diluted EPS 51.1 111.6
Basic average shares 49.2M 49.2M
Diluted average shares 49.2M 49.2M
EBITDA 5.6B 6.7B
Net income from continuing op.
Minority interests
Preferred stock dividends 0 0
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 2 hours 33 minutes

12:56
00:00
09:00
15:30
23:59

Trading Hours (Monday - Friday):

Main market
09:00 - 15:30
All times are displayed in the Asia/Tokyo timezone (JST, UTC+09:00).